📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Molecular Devices

1.1 - Company Overview

Molecular Devices Logo

Molecular Devices

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of analytical solutions for cell and protein biology, enabling customers to unravel complex biological systems. Offerings include AI-driven automated cell culture (CellXpress.ai), high-content confocal imaging (ImageXpress), SpectraMax microplate readers, SoftMax Pro software for data analysis, GxP compliance solutions, and an Organoid Innovation Center for 3D biological models.

Products and services

  • ImageXpress High-Content Confocal Imaging System: Delivers AI-driven technology enabling efficient, detailed confocal imaging for high-content cellular analysis, streamlining complex biological studies
  • SpectraMax Microplate Readers: Produces microplate readers for a variety of assays, supporting research in protein and cell biology with reliable performance and streamlined laboratory workflows, multi-assay
  • CellXpress.ai Automated Cell Culture System: Automates cell culture processes with machine learning–assisted monitoring, improving workflow efficiency and assay reliability across cell biology experiments

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Molecular Devices

BioGene Logo

BioGene

HQ: United Kingdom Website
  • Description: Provider of a solution-based portfolio of products, services, and support covering key application areas of molecular biology, dedicated to developing and implementing molecular and engineering technologies to improve access to diagnostic testing and enhance global health outcomes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioGene company profile →
Nebion Logo

Nebion

HQ: Switzerland Website
  • Description: Provider of precise curation and advanced analytics of public and private studies to enable the future of genomic research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nebion company profile →
Tessera Therapeutics Logo

Tessera Therapeutics

HQ: United States Website
  • Description: Provider of Gene Writing technology for permanent therapeutic alterations to the human genome, offering RNA Gene Writers to change base pairs, make small insertions, deletions or replacements, and integrate entire genes without double stranded breaks; DNA Gene Writers to durably write new DNA sequences with potential one-time cures; and a proprietary lipid nanoparticle delivery system for safe, effective nucleic acid delivery beyond the liver.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tessera Therapeutics company profile →
Emulate Logo

Emulate

HQ: United States Website
  • Description: Provider of advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Emulate company profile →
Ncardia Logo

Ncardia

HQ: The Netherlands Website
  • Description: Provider of iPSC-based drug discovery platforms and predictive human cellular assay systems to expedite drug discovery from hit identification to lead optimization. Offers Ncyte Smooth Muscle Cells, Astrocytes, Endothelial Cells, Neural Mix, and vCardiomyocytes for in vitro modeling, safety and efficacy testing, cardiovascular and neural screening, pharmacology, toxicity, electrophysiology, and disease modeling.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ncardia company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Molecular Devices

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Molecular Devices

2.2 - Growth funds investing in similar companies to Molecular Devices

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Molecular Devices

4.2 - Public trading comparable groups for Molecular Devices

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Molecular Devices

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Molecular Devices

What does Molecular Devices do?

Molecular Devices is a provider of analytical solutions for cell and protein biology, enabling customers to unravel complex biological systems. Offerings include AI-driven automated cell culture (CellXpress.ai), high-content confocal imaging (ImageXpress), SpectraMax microplate readers, SoftMax Pro software for data analysis, GxP compliance solutions, and an Organoid Innovation Center for 3D biological models.

Who are Molecular Devices's competitors?

Molecular Devices's competitors and similar companies include BioGene, Nebion, Tessera Therapeutics, Emulate, and Ncardia.

Where is Molecular Devices headquartered?

Molecular Devices is headquartered in United States.

How many employees does Molecular Devices have?

Molecular Devices has 1,000 employees 🔒.

When was Molecular Devices founded?

Molecular Devices was founded in 2010 🔒.

What sector and industry vertical is Molecular Devices in?

Molecular Devices is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Molecular Devices

Who are the top strategic acquirers in Molecular Devices's sector and industry

Top strategic M&A buyers and acquirers in Molecular Devices's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Molecular Devices?

Top strategic M&A buyers groups and sectors for Molecular Devices include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Molecular Devices's sector and industry vertical

Which are the top PE firms investing in Molecular Devices's sector and industry vertical?

Top PE firms investing in Molecular Devices's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Molecular Devices's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Molecular Devices's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Molecular Devices's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Molecular Devices include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Molecular Devices's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Molecular Devices?

The key public trading comparables and valuation benchmarks for Molecular Devices include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Molecular Devices for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Molecular Devices with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Molecular Devices's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Molecular Devices with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Molecular Devices's' sector and industry vertical?

Access recent funding rounds and capital raises in Molecular Devices's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Molecular Devices

Launch login modal Launch register modal